Trusted medical expertise in seconds.

Access 1,000+ clinical and preclinical articles. Find answers fast with the high-powered search feature and clinical tools.

Try free for 5 days
Evidence-based content, created and peer-reviewed by physicians. Read the disclaimer.

Hemolytic anemia

Last updated: September 3, 2020

Summarytoggle arrow icon

Hemolytic anemias are a group of conditions characterized by the breakdown of red blood cells. Hemolysis is caused by either abnormalities in the RBCs themselves (in hemoglobin, the RBC membrane, or intracellular enzymes), known as corpuscular anemia, or by external causes (immune-mediated or mechanical damage), known as as extracorpuscular anemia. All hemolytic anemias result in varying degrees of fatigue, pallor, and weakness (from asymptomatic disease to life-threatening hemolytic crisis), although some forms of hemolytic anemia have more specific findings (e.g., venous thrombosis in paroxysmal nocturnal hemoglobinuria). They also have common laboratory findings, including elevated indirect bilirubin and lactate dehydrogenase, reticulocytosis, and decreased haptoglobin levels. The Coombs test helps to distinguish between autoimmune (positive Coombs test) and nonautoimmune anemias (negative Coombs test). Treatment involves RBC transfusions as required but otherwise depends on the specific type of hemolytic anemia and its causes.

Types and etiologies of hemolytic anemia

Hemolytic anemias are characterized by an excessive breakdown of red blood cells (RBCs). They can be classified according to the cause of hemolysis (intrinsic or extrinsic) and by the location of hemolysis (intravascular or extravascular).

Type Definition Causes
By RBC pathology
Intrinsic hemolytic anemia
  • Increased destruction of RBCs due to a defect within the RBC
Extrinsic hemolytic anemia
  • Abnormal breakdown of normal RBCs
By location of RBC breakdown
Intravascular hemolytic anemia
  • Increased destruction of RBCs within the blood vessels
Extravascular hemolytic anemia

References: [3][4]

Serum studies [5][6][7]

General findings

Specific workup for hemolytic anemia [5][6]

Coombs test [9]

This test detects antibodies and/or complement proteins on the surface of RBC; (direct test) or in serum (indirect test). The test uses Coombs serum, which contains anti-human globulins. A positive result in a patient with hemolysis supports the diagnosis of antibody-mediated, extracorpuscular anemia.

Direct Coombs test

Indirect Coombs test

  • The patient's blood sample is purified so that only serum remains.
  • A donor's blood (RBC) sample is added.
  • Coombs serum is added as well.
  • The sample is analyzed for erythrocyte agglutination.
    • Erythrocyte agglutination indicates the test is positive: Preexisting, circulating, freeantibodies within patient's serum bind to the surface of the donor's RBCs, causing agglutination.
    • Absence of erythrocyte agglutination indicates the test is negative.
  • Indicated for detecting antibodies in:

The direct Coombs test detects antibodies attached directly to the RBC surface. The indirect (or not direct) Coombs test detects serum antibodies not bound to RBCs.

Peripheral blood smear [5][10]

Additional findings [11][12]

Erythrocytic membrane defects

Paroxysmal nocturnal hemoglobinuria (PNH)

Suspect PNH if a patient presents with hemolytic anemia, venous thrombosis, and pancytopenia!

Other examples

Enzyme defects

Pyruvate kinase deficiency [20][21][22]

Other examples


Hemoglobin C disease [23]

Hemoglobin Zurich [25]

Other examples

In hemoglobin C disease, there is an excess of lyCine (lysine) which substitutes the amino acid glutamic acid.

Isoimmune hemolytic anemia

Autoimmune hemolytic anemia (AIHA)

Cold agglutinin disease [26][27][28]

Cold weather is MMMMiserable: Cold (IgM) AIHA is seen in Malignancy (CLL), Mycoplasma pneumoniae, and Mononucleosis.

Warm agglutinin disease [28][29][32][33][34]

Warm weather is Great”: Warm AIHA is IgG mediated.

Microangiopathic hemolytic anemia [10][37]

Macroangiopathic hemolytic anemia

  1. Ram R, Adiraju KP, Gudithi S, Dakshinamurty KV. Renal Manifestations in Paroxysmal Nocturnal Hemoglobinuria. Indian J Nephrol. 2017; 27 (4): p.289–293. doi: 10.4103/0971-4065.205201 . | Open in Read by QxMD
  2. Risitano A. Paroxysmal nocturnal hemoglobinuria: pathophysiology, natural history and treatment options in the era of biological agents. Biologics: Targets & Therapy. 2008 : p.205. doi: 10.2147/btt.s1420 . | Open in Read by QxMD
  3. Kinoshita T, Inoue N. Relationship between aplastic anemia and paroxysmal nocturnal hemoglobinuria. Int J Hematol. 2002; 75 (2): p.117-22.
  4. Young NS, Maciejewski JP, Sloand E, et al. The relationship of aplastic anemia and PNH. Int J Hematol. 2002; 76 Suppl 2 : p.168-72.
  5. Mohammed AA, EL-Tanni H, Atiah TA-M, Atiah AA-M, Atiah MA-M, Rasmy AA. Paroxysmal Nocturnal Hemoglobinuria: From Bench to Bed. Indian Journal of Hematology and Blood Transfusion. 2016; 32 (4): p.383-391. doi: 10.1007/s12288-016-0654-2 . | Open in Read by QxMD
  6. Ebenbichler CF, Würzner R, Sandhofer AD, Niederwieser D, Dierich MP, Patsch JR. Anti-thymocyte globulin treatment of a patient for paroxysmal nocturnal haemoglobinuria-aplastic anaemia syndrome: complement activation and transient decrease of the PNH clone.. Immunobiology. 1997 .
  7. Hoekstra J, Leebeek FW, Plessier A, Raffa S, Darwish Murad S, Heller J, Hadengue A, Chagneau C, Elias E, Primignani M, Garcia-Pagan JC, Valla DC, Janssen HL; European Network for Vascular Disorders of the Liver.. Paroxysmal nocturnal hemoglobinuria in Budd-Chiari syndrome: findings from a cohort study.. Journal of Hepatology. 2009 .
  8. Prchal JT. Pyruvate kinase deficiency. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. updated: June 9, 2016. Accessed: February 8, 2017.
  9. Zanella A, Bianchi P, Fermo E. Pyruvate kinase deficiency. Haematologica. 2007; 92 (6): p.721-723. doi: 10.3324/haematol.11469 . | Open in Read by QxMD
  10. Bianchi P, Fermo E, Glader B, et al. Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency. Am J Hematol. 2018; 94 (1): p.149-161. doi: 10.1002/ajh.25325 . | Open in Read by QxMD
  11. Hemoglobin C Disease. Updated: November 10, 2016. Accessed: October 22, 2018.
  12. Fairhurst RM, Casella JF. Homozygous Hemoglobin C Disease. N Engl J Med. 2004; 350 (26): p.e24. doi: 10.1056/nejmicm030486 . | Open in Read by QxMD
  13. Hemoglobin Zurich. Updated: March 4, 2014. Accessed: August 3, 2020.
  14. Swiecicki PL, Hegerova LT, Gertz MA. Cold agglutinin disease. Blood. 2013; 122 (7): p.1114-1121. doi: 10.1182/blood-2013-02-474437 . | Open in Read by QxMD
  15. Berentsen S. New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia. Frontiers in Immunology. 2020; 11 . doi: 10.3389/fimmu.2020.00590 . | Open in Read by QxMD
  16. Hill A, Hill QA. Autoimmune hemolytic anemia. Hematology. 2018; 2018 (1): p.382-389. doi: 10.1182/asheducation-2018.1.382 . | Open in Read by QxMD
  17. Barcellini W, Fattizzo B. The Changing Landscape of Autoimmune Hemolytic Anemia. Frontiers in Immunology. 2020; 11 . doi: 10.3389/fimmu.2020.00946 . | Open in Read by QxMD
  18. Hansen DL, Möller S, Andersen K, Gaist D, Frederiksen H. Increasing Incidence and Prevalence of Acquired Hemolytic Anemias in Denmark, 1980–2016. Clinical Epidemiology. 2020; Volume 12 : p.497-508. doi: 10.2147/clep.s250250 . | Open in Read by QxMD
  19. Sonikpreet Sonikpreet, Gulshan Oberoi and Sarwan Kumar. Case Report: Autoimmune Hemolytic Anemia with Venous Thromboembolism, a Common Complication of a Rare Disease. Blood. 2014 .
  20. Schrier SL, Mentzer WC, Tirnauer JS. Warm Autoimmune Hemolytic Anemia: Treatment. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. updated: May 17, 2017. Accessed: August 22, 2017.
  21. Charles H. Packman. The Clinical Pictures of Autoimmune Hemolytic Anemia. Transfusion Medicine and Hemotherapy. 2015 .
  22. Autoimmune hemolytic anemia, warm agglutinin disease, cold agglutinin disease. . Accessed: May 17, 2019.
  23. Kalfa TA. Warm antibody autoimmune hemolytic anemia. Hematology. 2016; 2016 (1): p.690-697. doi: 10.1182/asheducation-2016.1.690 . | Open in Read by QxMD
  24. Schrier SL, Brugnara C. Pathogenesis of autoimmune hemolytic anemia: Warm agglutinins and drugs. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. updated: September 19, 2018. Accessed: February 7, 2019.
  25. Microangiopathic Hemolytic Anemia (MAHA). . Accessed: May 21, 2019.
  26. Phillips J, Henderson AC. Hemolytic Anemia: Evaluation and Differential Diagnosis. Am Fam Physician. 2018; 98 (6): p.354-361.
  27. Westphal RG, Azen EA.. Macroangiopathic hemolytic anemia due to congenital cardiovascular anomalies.. The Journal of the American Medical Association. 1971 .
  28. Muneeba Malik, Abeera Mansur. Copper sulphate poisoning and exchange transfusion. Saudi Journal of Kidney Disease and Transplantation. 2011 .
  29. SR Mehta, VSM and VK Sashindran. Clinical Features And Management Of Snake Bite. Medical Journal Armed Forces India. 2011 .
  30. Hemolytic Anemia. Updated: February 8, 2017. Accessed: February 8, 2017.
  31. Schrier SL, Mentzer WC, Tirnauer JS. Diagnosis of Hemolytic Anemia in the Adult. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. updated: July 18, 2016. Accessed: August 22, 2017.
  32. Shih AWY, McFarlane A, Verhovse M. Haptoglobin testing in hemolysis: Measurementand interpretation. Am J Hematol. 2014; 89 (4): p.443-447. doi: 10.1002/ajh.23623 . | Open in Read by QxMD
  33. Takayo Nagao, MD, Makoto Hirokawa, MD, PhD. Diagnosis and treatment of macrocytic anemias in adults. Journal of General and Family Medicine. 2017 .
  34. DAVID A. SEARS, PEARL R. ANDERSON, ARTHUR L. FOY, HAROLD L. WILLIAMS, AND WILLIAM H. CROSBY. Urinary Iron Excretion and Renal Metabolism of Hemoglobin in Hemolytic Diseases. Blood Journal. 1966 .
  35. Coombs Test : Types, Principle, Procedure and Interpretation. Updated: January 11, 2020. Accessed: October 29, 2020.
  36. Brodsky RA. Paroxysmal nocturnal hemoglobinuria. Blood. 2014; 124 (18): p.2804-2811. doi: 10.1182/blood-2014-02-522128 . | Open in Read by QxMD
  37. Rai KR, Jain P. Chronic lymphocytic leukemia (CLL)-Then and now. Am J Hematol. 2016; 91 (3): p.330-340. doi: 10.1002/ajh.24282 . | Open in Read by QxMD
  38. Vivian C. Ejindu, Andrew L. Hine, Mohammad Mashayekhi, Philip J. Shorvon, Rakesh R. Misra. Musculoskeletal Manifestations of Sickle Cell Disease. Radiology. 2007 .
  39. Kasper DL, Fauci AS, Hauser SL, Longo DL, Lameson JL, Loscalzo J. Harrison's Principles of Internal Medicine. McGraw-Hill Education ; 2015
  40. Herold G. Internal Medicine. Herold G ; 2014
  41. Brodsky RA. Clinical manifestations and diagnosis of paroxysmal nocturnal hemoglobinuria. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. updated: April 25, 2016. Accessed: February 8, 2017.
  42. Parker CJ. Management of paroxysmal nocturnal hemoglobinuria in the era of complement inhibitory therapy. Hematology Am Soc Hematol Educ Program. 2011; 2011 : p.21-29. doi: 10.1182/asheducation-2011.1.21 . | Open in Read by QxMD
  43. Schrier SL. Cold agglutinin disease. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. updated: October 5, 2016. Accessed: February 8, 2017.
  44. Brodsky RA, Schrier SL, Rosmarin AG. Pathogenesis of Paroxysmal Nocturnal Hemoglobinuria. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. updated: June 2, 2016. Accessed: August 30, 2017.
  45. Steinberg MH and Quinn CT. Unstable hemoglobin variants. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. updated: July 23, 2020. Accessed: August 3, 2020.